Literature DB >> 22251938

New criteria for histologic grading of colorectal cancer.

Hideki Ueno1, Yoshiki Kajiwara, Hideyuki Shimazaki, Eiji Shinto, Yojiro Hashiguchi, Kuniaki Nakanishi, Kazunari Maekawa, Yuka Katsurada, Takahiro Nakamura, Hidetaka Mochizuki, Junji Yamamoto, Kazuo Hase.   

Abstract

Conventional tumor grading systems based on the degree of tumor differentiation may not always be optimal because of difficulty in objective assessment and insufficient prognostic value for decision making in colorectal cancer (CRC) treatment. This study aimed to determine the importance of assessing the number of poorly differentiated clusters as the primary criterion for histologic grading of CRC. Five hundred consecutive patients with curatively resected stage II and III CRCs (2000 to 2005) were pathologically reviewed. Cancer clusters of ≥5 cancer cells and lacking a gland-like structure were counted under a ×20 objective lens in a field containing the highest number of clusters. Tumors with <5, 5 to 9, and ≥10 clusters were classified as grade (G)1, G2, and G3, respectively (n=156, 198, and 146 tumors, respectively). Five-year disease-free survival rates were 96%, 85%, and 59% for G1, G2, and G3, respectively (P<0.0001). Poorly differentiated clusters affected survival outcome independent of T and N stages and could help in more effective stratification of patients by survival outcome compared with tumor staging (Akaike information criterion, 1086.7 vs. 1117.0; Harrell concordance index, 0.73 vs. 0.67). The poorly differentiated cluster-based grading system showed a higher weighted κ coefficient for interobserver variability (5 observers) compared with conventional grading systems (mean, 0.66 vs. 0.52; range, 0.55 to 0.73 vs. 0.39 to 0.68). Our novel histologic grading system is expected to be less subjective and more informative for prognostic prediction compared with conventional tumor grading systems and TNM staging. It could be valuable in determining individualized postoperative CRC treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22251938     DOI: 10.1097/PAS.0b013e318235edee

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  61 in total

Review 1.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.

Authors:  Britta Kleist; Micaela Poetsch
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 2.  Controversies in the pathological assessment of colorectal cancer.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.

Authors:  Luca Reggiani Bonetti; Simona Lionti; Enrica Vitarelli; Valeria Barresi
Journal:  Virchows Arch       Date:  2017-08-17       Impact factor: 4.064

4.  The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.

Authors:  Serena Ammendola; Giulia Turri; Irene Marconi; Giulia Burato; Sara Pecori; Anna Tomezzoli; Cristian Conti; Corrado Pedrazzani; Valeria Barresi
Journal:  Virchows Arch       Date:  2020-06-23       Impact factor: 4.064

5.  Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer.

Authors:  Gorana Aralica; Martina Šarec Ivelj; Arijana Pačić; Josip Baković; Marija Milković Periša; Anteja Krištić; Paško Konjevoda
Journal:  Pathol Oncol Res       Date:  2020-07-02       Impact factor: 3.201

6.  Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.

Authors:  Valeria Barresi; Giovanni Branca; Antonio Ieni; Luca Reggiani Bonetti; Luigi Baron; Stefania Mondello; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2014-04-27       Impact factor: 4.064

7.  Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.

Authors:  Valeria Barresi; Luca Reggiani Bonetti; Giovanni Branca; Carmela Di Gregorio; Maurizio Ponz de Leon; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2012-10-24       Impact factor: 4.064

8.  A Transverse Colectomy is as Safe as an Extended Right or Left Colectomy for Mid-Transverse Colon Cancer.

Authors:  Lieve G J Leijssen; Anne M Dinaux; Ramzi Amri; Hiroko Kunitake; Liliana G Bordeianou; David L Berger
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

9.  Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial-mesenchymal transition.

Authors:  Raul S Gonzalez; Won Jae Huh; Justin M M Cates; Kay Washington; R Daniel Beauchamp; Robert J Coffey; Chanjuan Shi
Journal:  Histopathology       Date:  2016-10-28       Impact factor: 5.087

10.  Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.

Authors:  Hideki Ueno; Kazuo Hase; Yojiro Hashiguchi; Hideyuki Shimazaki; Shinji Yoshii; Shin-ei Kudo; Masafumi Tanaka; Yoshito Akagi; Takeshi Suto; Shinji Nagata; Keiji Matsuda; Koji Komori; Kazuhiko Yoshimatsu; Yasuhiko Tomita; Shozo Yokoyama; Eiji Shinto; Takahiro Nakamura; Kenichi Sugihara
Journal:  J Gastroenterol       Date:  2013-09-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.